Discover
BNOX
Neuphoria Therapeutics Inc.
0.25
undefined x undefined
undefined x undefined
bid
ask
+
0.01
4.59%
04:00 PM
| Ytd | -77.20% | |
| 1y | -77.20% |
0.24
day range
0.29
52 week range
| Open | 0.25 | Prev Close | 0.24 | Low | 0.24 | High | 0.29 | Mkt Cap | N/A |
| Vol | 906.40K | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | -0.14 |
| Beta | -0.07 | Short Ratio | 0.13 | Inst. Own | 16.22% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 9.60 |
| Income Statement | |||
| Weighted Average Shares | 1.49B | ||
| Balance Sheet | |||
| Cash and Equivalents | 14.87M | ||
| Cash and Equivalents (USD) | 10.11M | ||
| Investments | 119.00K | ||
| Investments Non-Current | 119.00K | ||
| Trade and Non-Trade Receivables | 475.87K | ||
| Current Assets | 16.86M | ||
| Property, Plant & Equipment Net | 416.12K | ||
| Total Assets | 38.85M | ||
| Debt Current | 1.30M | ||
| Total Debt | 1.57M | ||
| Current Liabilities | 4.42M | ||
| Debt Non-Current | 272.14K | ||
| Total Liabilities | 9.82M | ||
| Accumulated Retained Earnings (Deficit) | -218.63M | ||
| Shareholders Equity | 29.03M | ||
| Shareholders Equity (USD) | 19.75M | ||
| Assets Non-Current | 22.00M | ||
| Total Debt (USD) | 1.07M | ||
| Goodwill and Intangible Assets | 21.46M | ||
| Liabilities Non-Current | 5.40M | ||
| Trade and Non-Trade Payables | 2.56M | ||
| Tax Assets | 145.16K | ||
| Tax Liabilities | 1.52M | ||